CITI Training Practice Exam

The International Conference on Harmonisation (ICH) brings together regulatory authorities and pharmaceutical industry experts from around the world to discuss and develop guidelines for the approval of pharmaceutical products. One of the primary purposes of the ICH is to minimize the need for redundant research by promoting harmonization of technical requirements for pharmaceutical products. This means that the ICH works to establish common standards and guidelines for drug development, reducing the need for companies to conduct multiple studies and trials in different regions or countries. Therefore, the primary purpose of the ICH is not to require publication of negative trial results (A), develop mandatory worldwide regulations for drug development (B), or require FDA registration of worldwide clinical trials (C). While these may be important outcomes of the work of the ICH, they are not its primary purpose.